Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial.
Clin Exp Rheumatol
; 41(9): 1831-1837, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37497730
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Antirheumatic Agents
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Clin Exp Rheumatol
Year:
2023
Type:
Article
Affiliation country:
France